These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 975144)

  • 1. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of vasoactive substances on superficial human veins in vivo.
    Aellig WH
    Int Angiol; 1985; 4(2):235-42. PubMed ID: 3913713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed.
    Aellig WH; Berde B
    Br J Pharmacol; 1969 Jul; 36(3):561-70. PubMed ID: 5789809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of ergot compounds on compliance of superficial hand veins in man.
    Aellig WH
    Postgrad Med J; 1976; 52suppl 1():21-23. PubMed ID: 959123
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods for studying drug effects on superficial human veins.
    Aellig WH
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):321-4. PubMed ID: 3840550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venoconstrictor effect of dihydroergotamine in superficial hand veins.
    Aellig WH
    Eur J Clin Pharmacol; 1974; 7(2):137-9. PubMed ID: 4855381
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative plethysmographic study of the venoconstrictor effect of dihydroergotamine and dihydroergotoxine on the deep veins of the calf in healthy subjects and patients suffering from varicosis.
    Barthel W; Grossmann K
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):458-64. PubMed ID: 7141753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.
    Aellig WH
    Eur J Clin Pharmacol; 1984; 26(2):239-42. PubMed ID: 6547094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial hand and foot veins show no difference in sensitivity to constrictor agents.
    Aellig WH
    Clin Pharmacol Ther; 1990 Jul; 48(1):96-101. PubMed ID: 2369808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
    Aellig WH; Rosenthaler J
    Eur J Clin Pharmacol; 1986; 30(5):581-4. PubMed ID: 3758146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
    den Boer MO; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog.
    CARPI A; VIRNO M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):232-9. PubMed ID: 13446379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.
    Aellig WH; Nüesch E
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):106-12. PubMed ID: 403149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of ergot alkaloids in clinical use.
    Berde B
    Med J Aust; 1978 Nov; 2(3 Suppl):3-13. PubMed ID: 370528
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular effects of dihydrogenated ergot alkaloids. Comparative effects of dihydroergostine and dihydroergotamine on the blood flow and the capacitance vessels in the human calf studied by plethysmography.
    Ulrich J; Siggaard-Andersen J
    Angiology; 1971 Dec; 22(11):622-8. PubMed ID: 5003295
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
    Looper ML; Edrington TS; Moubarak AS; Callaway TR; Rosenkrans CF
    Foodborne Pathog Dis; 2008 Oct; 5(5):599-604. PubMed ID: 18681792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.